66 related articles for article (PubMed ID: 21160189)
1. RAR-beta expression is associated with early volumetric changes to radiation therapy in cervical cancer.
Kim WY; Lee JW; Park YA; Choi JJ; Sung CO; Song SY; Choi CH; Kim TJ; Huh SJ; Kim BG; Bae DS
Gynecol Obstet Invest; 2011; 71(1):11-8. PubMed ID: 21160189
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells.
Geisen C; Denk C; Gremm B; Baust C; Karger A; Bollag W; Schwarz E
Cancer Res; 1997 Apr; 57(8):1460-7. PubMed ID: 9108446
[TBL] [Abstract][Full Text] [Related]
5. Gene identification by cDNA arrays in HPV-positive cervical cancer.
Vázquez-Ortíz G; Ciudad CJ; Piña P; Vazquez K; Hidalgo A; Alatorre B; Garcia JA; Salamanca F; Peralta-Rodriguez R; Rangel A; Salcedo M
Arch Med Res; 2005; 36(5):448-58. PubMed ID: 16099320
[TBL] [Abstract][Full Text] [Related]
6. [Identification biomarkers for cervical cancer in peripheral blood lymphocytes by oligonucleotide microarrays].
Sheng J; Zhang WY
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(37):2611-5. PubMed ID: 21162926
[TBL] [Abstract][Full Text] [Related]
7. [Screening for cervical cancer-related genes and their bioinformatics analysis].
Chen SZ; Ma WL; Zheng WL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):585-8. PubMed ID: 18495597
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers for cervical cancer in peripheral blood lymphocytes using oligonucleotide microarrays.
Sheng J; Zhang WY
Chin Med J (Engl); 2010 Apr; 123(8):1000-5. PubMed ID: 20497704
[TBL] [Abstract][Full Text] [Related]
10. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis.
Harima Y; Togashi A; Horikoshi K; Imamura M; Sougawa M; Sawada S; Tsunoda T; Nakamura Y; Katagiri T
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):237-48. PubMed ID: 15337562
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis.
Harima Y; Ikeda K; Utsunomiya K; Shiga T; Komemushi A; Kojima H; Nomura M; Kamata M; Sawada S
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1232-9. PubMed ID: 19857786
[TBL] [Abstract][Full Text] [Related]
12. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
13. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer.
Kim TJ; Choi JJ; Kim WY; Choi CH; Lee JW; Bae DS; Son DS; Kim J; Park BK; Ahn G; Cho EY; Kim BG
Cancer Sci; 2008 Jan; 99(1):31-8. PubMed ID: 17986283
[TBL] [Abstract][Full Text] [Related]
15. [Cervical cancer and DNA microarrays: tumour marker identification].
Acevedo Rocha CG; Alvarez E; Zafra de la Rosa G; Alvarez Navarro M; Gariglio P
Ginecol Obstet Mex; 2007 Apr; 75(4):205-13. PubMed ID: 17849800
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of early adenocarcinoma of the uterine cervix by oligonucleotide microarray.
Liao LM; Zheng M; Huang L; Ding H; He L; Zhang Y; Wang HY
Arch Gynecol Obstet; 2011 Apr; 283(4):861-9. PubMed ID: 20496073
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.
Tewari D; Monk BJ; Al-Ghazi MS; Parker R; Heck JD; Burger RA; Fruehauf JP
Gynecol Oncol; 2005 Oct; 99(1):84-91. PubMed ID: 16109440
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic index as predictive marker for radiosensitivity of cervical carcinoma: evaluation of membrane fluidity, biochemical parameters and apoptosis after the first dose of fractionated radiotherapy to patients.
Bhosle SM; Huilgol NG; Mishra KP
Cancer Detect Prev; 2005; 29(4):369-75. PubMed ID: 16125335
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
